Jasper Basit
Family Medicine · Corcoran, CANPI 1841583028
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $521 and has fallen 89.1% since, to $57 in 2025.
Across 144 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$482
- Lilly USA, LLC$308
- Johnson & Johnson$186
- Amgen$182
- AbbVie$159
- AstraZeneca$155
- plus $808 from 20 others
What the payments were for
- Food & beverage$2,26699%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $482 |
| Lilly USA, LLC | 20 | $308 |
| Johnson & Johnson | 11 | $186 |
| Amgen(2 entities) | 9 | $182 |
| AbbVie(2 entities) | 8 | $159 |
| AstraZeneca | 8 | $155 |
| Boehringer Ingelheim | 7 | $128 |
| Pfizer | 5 | $90 |
| Merck | 5 | $81 |
| Amarin Pharma, Inc. | 4 | $74 |
| Phathom Pharmaceuticals, Inc. | 1 | $51 |
| GSK | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 1 | $38 |
| Abbott | 2 | $37 |
| Medtronic | 1 | $30 |
| Edwards Lifesciences | 1 | $29 |
| Dexcom, Inc. | 1 | $28 |
| Bayer | 1 | $27 |
| Exact Sciences | 1 | $23 |
| Baxter Healthcare | 1 | $21 |
| Philips North America LLC | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Eisai Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$2,279 in reported general payments places this provider in the 85th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 80 | $1,169 |
| Atorvastatin Calcium | 54 | $714 |
| Metformin Hcl | 65 | $654 |
| Lisinopril | 63 | $578 |
| Simvastatin | 30 | $526 |
| Metoprolol Succinate | 23 | $482 |
| Losartan Potassium | 42 | $433 |
| Amlodipine Besylate | 41 | $401 |
| Rosuvastatin Calcium | 18 | $371 |
| Glipizide | 23 | $331 |
| Gabapentin | 16 | $319 |
| Tamsulosin Hcl | 24 | $319 |
| Chlorthalidone | 16 | $183 |
| Hydroxyzine Hcl | 12 | $152 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 13 | $141 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Corcoran
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.